Anthony Petrone
Stock Analyst at Mizuho
(3.72)
# 686
Out of 5,182 analysts
218
Total ratings
49.11%
Success rate
7.64%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MNKD MannKind | Maintains: Outperform | $10 → $8 | $2.79 | +186.74% | 1 | Apr 13, 2026 | |
| MDT Medtronic | Maintains: Outperform | $125 → $120 | $81.90 | +46.52% | 8 | Apr 13, 2026 | |
| LNTH Lantheus Holdings | Maintains: Outperform | $85 → $95 | $83.55 | +13.70% | 9 | Apr 13, 2026 | |
| ISRG Intuitive Surgical | Maintains: Neutral | $575 → $525 | $466.64 | +12.51% | 7 | Apr 13, 2026 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $85 → $70 | $55.11 | +27.02% | 9 | Apr 13, 2026 | |
| HAE Haemonetics | Maintains: Outperform | $80 → $70 | $59.84 | +16.98% | 18 | Apr 13, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Outperform | $95 → $90 | $68.50 | +31.39% | 7 | Apr 13, 2026 | |
| EW Edwards Lifesciences | Maintains: Outperform | $100 → $95 | $82.28 | +15.46% | 11 | Apr 13, 2026 | |
| EMBC Embecta | Maintains: Neutral | $14 → $12 | $9.03 | +32.89% | 4 | Apr 13, 2026 | |
| BSX Boston Scientific | Maintains: Outperform | $115 → $90 | $58.45 | +53.98% | 10 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $30 → $24 | $10.90 | +120.18% | 7 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $21 | $12.94 | +62.29% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $100 | $64.40 | +55.28% | 10 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $22 | $18.63 | +18.09% | 3 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $90 | $59.32 | +51.72% | 4 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $10 | $3.40 | +194.12% | 5 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $72 | $61.29 | +17.47% | 10 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $120 | $83.09 | +44.42% | 4 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $100 | $63.09 | +58.50% | 16 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $41.99 | -4.74% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $110 → $100 | $75.40 | +32.63% | 11 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $310 → $300 | $217.14 | +38.16% | 18 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $135 | $135.52 | -0.38% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $140 → $135 | $93.86 | +43.83% | 6 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $18 | $26.71 | -32.60% | 8 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $200 → $175 | $119.63 | +46.28% | 10 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $40 | $7.18 | +457.10% | 1 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $58 | $62.09 | -6.59% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $63 → $67 | $112.40 | -40.39% | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $200 → $175 | $82.80 | +111.35% | 3 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $30 → $25 | $12.07 | +107.13% | 3 | May 13, 2020 |
MannKind
Apr 13, 2026
Maintains: Outperform
Price Target: $10 → $8
Current: $2.79
Upside: +186.74%
Medtronic
Apr 13, 2026
Maintains: Outperform
Price Target: $125 → $120
Current: $81.90
Upside: +46.52%
Lantheus Holdings
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $95
Current: $83.55
Upside: +13.70%
Intuitive Surgical
Apr 13, 2026
Maintains: Neutral
Price Target: $575 → $525
Current: $466.64
Upside: +12.51%
Inspire Medical Systems
Apr 13, 2026
Maintains: Outperform
Price Target: $85 → $70
Current: $55.11
Upside: +27.02%
Haemonetics
Apr 13, 2026
Maintains: Outperform
Price Target: $80 → $70
Current: $59.84
Upside: +16.98%
GE HealthCare Technologies
Apr 13, 2026
Maintains: Outperform
Price Target: $95 → $90
Current: $68.50
Upside: +31.39%
Edwards Lifesciences
Apr 13, 2026
Maintains: Outperform
Price Target: $100 → $95
Current: $82.28
Upside: +15.46%
Embecta
Apr 13, 2026
Maintains: Neutral
Price Target: $14 → $12
Current: $9.03
Upside: +32.89%
Boston Scientific
Apr 13, 2026
Maintains: Outperform
Price Target: $115 → $90
Current: $58.45
Upside: +53.98%
Apr 13, 2026
Maintains: Outperform
Price Target: $30 → $24
Current: $10.90
Upside: +120.18%
Mar 31, 2026
Initiates: Outperform
Price Target: $21
Current: $12.94
Upside: +62.29%
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $64.40
Upside: +55.28%
Feb 20, 2026
Maintains: Neutral
Price Target: $21 → $22
Current: $18.63
Upside: +18.09%
Feb 13, 2026
Maintains: Outperform
Price Target: $78 → $90
Current: $59.32
Upside: +51.72%
Dec 17, 2025
Maintains: Outperform
Price Target: $12 → $10
Current: $3.40
Upside: +194.12%
Dec 17, 2025
Maintains: Outperform
Price Target: $70 → $72
Current: $61.29
Upside: +17.47%
Dec 17, 2025
Maintains: Outperform
Price Target: $100 → $120
Current: $83.09
Upside: +44.42%
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $100
Current: $63.09
Upside: +58.50%
Dec 1, 2025
Initiates: Outperform
Price Target: $40
Current: $41.99
Upside: -4.74%
Nov 11, 2025
Maintains: Outperform
Price Target: $110 → $100
Current: $75.40
Upside: +32.63%
Oct 31, 2025
Maintains: Outperform
Price Target: $310 → $300
Current: $217.14
Upside: +38.16%
Aug 1, 2025
Maintains: Neutral
Price Target: $130 → $135
Current: $135.52
Upside: -0.38%
Jul 18, 2025
Maintains: Neutral
Price Target: $140 → $135
Current: $93.86
Upside: +43.83%
Jul 16, 2025
Maintains: Neutral
Price Target: $17 → $18
Current: $26.71
Upside: -32.60%
Apr 16, 2025
Maintains: Outperform
Price Target: $200 → $175
Current: $119.63
Upside: +46.28%
Apr 10, 2025
Initiates: Outperform
Price Target: $40
Current: $7.18
Upside: +457.10%
Mar 6, 2025
Maintains: Buy
Price Target: $54 → $58
Current: $62.09
Upside: -6.59%
Aug 3, 2023
Downgrades: Hold
Price Target: $63 → $67
Current: $112.40
Upside: -40.39%
Nov 5, 2021
Maintains: Buy
Price Target: $200 → $175
Current: $82.80
Upside: +111.35%
May 13, 2020
Maintains: Hold
Price Target: $30 → $25
Current: $12.07
Upside: +107.13%